Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous vs IV Furosemide in Decompensated Heart Failure
NCT02579057Phase 3Completed
- Sponsor
- Johns Hopkins University
- Start
- Feb 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of furosemide in heart failure (HF), sponsored by Johns Hopkins University. Started Feb 2016; status: completed.
02
Drugs
furosemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02579057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02579057.